Click on headlines below to download research

ByFavo – poised for autumn US launch
Paion | 07/07/2020

In a breakthrough achievement for Paion, the FDA has approved ByFavo (remimazolam) for US sale for procedural sedation (PS) taking under 30 minutes –…

An encouraging update
Numis Corporation | 07/07/2020

Numis’ update for Q320 was positive, reflecting both the need for equity funding in the market and the strength of the group’s franchise as…

Eye of the tiger
Hutchison China MediTech | 06/07/2020

Hutchison China MediTech (HCM) is on the brink of global launches of two assets from its internally developed oncology portfolio. In 2022 we expect US…

Eye of the tiger
Hutchison China MediTech | 06/07/2020

Hutchison China MediTech (HCM) is on the brink of global launches of two assets from its internally developed oncology portfolio. In 2022 we expect US…

Strong data in retinal therapy shows long effects
ReNeuron Group | 06/07/2020

ReNeuron has released further follow-up data from the ongoing human retinal progenitor cell (hRPC) trial, which shows a robust sustained averaged response.…

Implementing strategy in COVID-affected markets
Walker Greenbank | 06/07/2020

Walker Greenbank has a tangible strategic impetus under its new management team with a clear business model migration plan. While COVID-19 related market…

Cementing relationship with Peel Environmental
Powerhouse Energy Group | 06/07/2020

Over the last 18 months, Powerhouse has cemented its relationship with Peel Environmental, which is targeting the development of at least 30 distributed…

BYFAVO receives FDA approval
Acacia Pharma | 06/07/2020

The US FDA has approved BYFAVO (remimazolam) for injection, a very rapid onset/offset intravenous benzodiazepine sedative for use during invasive medical…

Delivering operationally and financially
Bragg Gaming Group | 06/07/2020

Bragg’s Q120 results demonstrated strong revenue growth (44% y-o-y), adjusted EBITDA margin expansion (to 8.7%) and improved free cash flow generation.…

Improving delivery of existing drug products
Suda Pharmaceuticals | 06/07/2020

SUDA Pharmaceuticals has focused on reformulating established drugs into oro-mucosal spray formulations for better bioavailability. Its lead commercial…